Affirm insider Levchin sells 14,953 shares under 10b5-1; 4M options vested
Rhea-AI Filing Summary
Max Levchin, CEO and director of Affirm Holdings, Inc. (AFRM), reported transactions on 08/18/2025. The filing shows an acquisition and a contemporaneous sale of 14,953 Class A common shares effected under a Rule 10b5-1 trading plan adopted March 17, 2025. The shares were acquired via exercise of performance-based stock options at an exercise price of $49.00 and sold at a weighted average price of $80.05 per share, resulting in no direct Class A shares owned following the sale. The reporting person discloses indirect ownership of 735,294 Class A shares held by the Levchin 2012 Irrevocable Trust and states that, as of 08/20/2025, 4,000,000 stock options have been earned and are vested from a multi-year Value Creation Award. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transaction executed under a Rule 10b5-1 plan, which provides clarity on timing and intent.
- Disclosure that 4,000,000 stock options are earned and vested as of 08/20/2025, clarifying incentive compensation status.
- Continued indirect ownership of 735,294 shares via the Levchin 2012 Irrevocable Trust, indicating sustained economic exposure.
Negative
- Direct Class A common stock ownership reduced to zero following the exercise and sale of 14,953 shares.
- Sale of shares by the CEO could be perceived as insider liquidity, though executed under a pre-established plan.
Insights
TL;DR: CEO exercised options and sold a small parcel under a 10b5-1 plan; indirect holdings remain significant.
The filing documents a routine exercise-and-sale transaction under a pre-established Rule 10b5-1 plan, where 14,953 option-derived shares were exercised at $49 and sold at a weighted average of $80.05. The transaction reduced direct share ownership to zero while leaving substantial indirect exposure through a trust of 735,294 shares and vested options totaling 4,000,000. For investors, this is primarily an insider liquidity event rather than a corporate-change signal; no additional transfers, pledges, or new grants beyond the previously disclosed Value Creation Award terms are reported.
TL;DR: Transactions comply with a documented 10b5-1 plan and include disclosure of trust-held shares and vested performance options.
The report clearly states the transactions were executed pursuant to a 10b5-1 trading plan adopted March 17, 2025, which provides affirmative-defense coverage. The form discloses indirect trust ownership and the vesting status of a multi-year performance award, which supports transparency in insider reporting. There are no indications in this filing of accelerated vesting, unusual transfers, or changes to voting/investment power over trust assets; the reporting person disclaims beneficial ownership beyond pecuniary interest in the trust shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Based Stock Options | 14,953 | $0.00 | -- |
| Exercise | Class A Common Stock | 14,953 | $49.00 | $733K |
| Sale | Class A Common Stock | 14,953 | $80.05 | $1.20M |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2025. Represents the weighted average sale price of the shares sold from $80.00 to $80.105 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. As joint settlors of the Levchin 2012 Irrevocable Trust, the Reporting Person and his spouse jointly have the right to acquire the shares held by the trust but do not have voting or investment power over such shares. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The Reporting Person was granted a multi-year performance-based stock option (the "Value Creation Award") on January 12, 2021. The Value Creation Award is divided into ten tranches which the Reporting Person may earn by satisfying a performance condition within a five-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer. The earned tranches of the Value Creation Award becomes vested and exercisable upon the satisfaction of a time condition. Any portion of the Value Creation Award that has not been earned by the fifth anniversary of the grant date will be forfeited. As of August 20, 2025, the Reporting Person has earned 4,000,000 stock options, all of which have vested.
